Hirra HussainPostdoctoral Research Associate at Manchester Institute of Biotechnology, University of Manchester
Hirra completed her PhD in Biotechnology at the University of Manchester in 2016. Currently, she works as a post-doctoral researcher at the University in collaboration with UCB Pharma. Current research interests are in the molecular understanding of poor recombinant protein production of novel format antibodies and the use of engineering strategies to overcome this challenge.
Hirra is currently the secretary of the ESACT-UK Society.